TLR4 and peripheral neuropathy: Intrathecal administration of the recombinant AIBP protein reduces TLR4 dimerization and lipid raft levels, the key characteristics of TLR4 inflammarafts, and alleviates tactile allodynia in a mouse model of chemotherapy-induced peripheral neuropathy [5].